Member Info for InContext

There is a half decent thread over on ADVFN explaining whats going on. Its all to do with rebalancing from non inclusion in the UK indices which effects tracker funds ability to hold shares. Its a 3% storm in a tea cup. BATM already OK a share buy back to counter this by intentions to buy back and cancel 10% of company shares. Its an Ab Fab chance for investors to buy ......

March 17th BATM have an extraordinary meeting to ratify the proposed buy back of 10% @44million of the company's shares. This will be done from existing funds the company have on deposit. Any holders are about to see their investment go up considerably for doing nothing ! Given the oversold SP position the timing is most opportune.

hTTps://www.youtube.com/watch?v=1b7KD9pE20A

All divisions seeing growth with cyber now adding to full order books and a sizeable backlog. Stupidly undervalued.

Results came in as expected. Any concerns about where future growth is coming from should be allayed. Edgility revenue started to trickle in, new RCA platform for identification and treatment for infectious diseases due to be rolled out in May, Cyber especially in todays environment should do very well indeed, pathogenic waste treatment plants with several key advances very much on course. Huge growing cash pile with more than enough for the share buy back. Company is delighted with the results and we should be also.

BATM has a support value at 85p and a sum of the parts @160p on last years results IMO and FWIW.
The recent SP collapse happened against a perfect storm of misinformation. We live in absurd times.
Mind you the tech sector has seen 40% drop in many otherwise solid shares so thats a large part of it.

BATM has been a defensive stock in the past as they are well funded and don't need to go the the markets for cash. All R&D costs are handled in house. Last years strip out value for BATM was @85p and thats on last years results. Diagnostics, NFV, Cyber are all in the essential items camp.

There have been a plethora of articles recently about the wind down for 3G. Providers need to scramble if they want to stay in the frame. The demand for SOHO solutions and video conferencing demand and information sharing with virtually no latency is where we are heading. The pandemic restricted roll out for NFV enabled devices where the company had to get technicians on site. I would expect that Telco has a large backlog of orders.

Its a very opportune move by BATM to buy back shares especially as the current valuation is half what it reasonably should be at this point in time. Not only does it get around the withholding tax but the 10% buyback at these levels is more like 20% boost for shareholders. I am assuming the company will cancel the shares. It will more than counter the few shares that have to be unloaded from Index funds which on paper would have had little effect in any case.

Few more days like today with a good set of results might see momentum return. Due to the UK indices fiasco we need to clear forced sellers and get the volume and interest up.

This is significant as Telco have had a long relationship with Advantech and numerous POC etc. This is now in the market and pre installed on white box UCPE equipment for which Telco get a licensing fee. In other words the revenue part of this is now activated.

The importance of this announcement is that Advantech products (in this field) are now coming pre installed with Edgility. The demand for SOHO solutions and UCPE equipment that can handle todays demands means these solutions are well out of the POC stage and being offered to the market. Telco systems gets a licensing fee for all of this. ie They are now getting revenue.

Edgility formerly NFVTime is an essential NFV platform for the Telecoms industry. NFV has long since gone from a "maybe" when Telco started becoming involved to a standard for the industry. Telco systems really are one of the earliest players in this field. The flexibility to run on ARM and Intel was a first in the industry and I am not sure that even today anyone else is offering this option. revenue comes from licensing which is a high margin cumulative stream.

Agricore I agree with your overall take.
the shares have been on a negative run ever since they peaked out at the height of the Covid hysteria. It was the perfect storm of perceived negative events that sent them lower all of which as we are now seeing was unfounded.
BATM mention growth in both divisions with as expected the medical to outperform, but what could really set the cat amongst the pigeons is if we see revenue from NFV Edgility start to trickle in. This is a cumulative high margin revenue shot as Marom explained in a recent podcast. They are multi year contracts so new business is added on to the pile.

Shore have had a very real tendency to downplay results and future guidance. Marom is on the board at Shore or was. I have never seen them underperform Shores outlook, so you might say if Shore says they are good they are. They got it from the horses mouth.

The Stock Market hardly ever makes any sense over the shorter term but as the results due Feb 28th are published the doubt should come out of the equation. ST is not incorrect in his rating and normally companies like this would be trading at a premium to reflect growth in earnings and more importantly in EPS driven by improved margins. I would assume ST will want to see the published figures before commenting. The very considerable IP the company has is not even being credited to the mix, Edgility in Telco Systems and the Medical/Ador new RCA testing platform are seriously valuable assets that are not yet contributing to sales. There is not a listing problem only their inclusion in UK based company indices which has a very limited effect.

Should have added you get the 1.5% return plus the 10% enhanced value from the share buy back plus a share at half price.

The 10% share buy back proposed offers a great way to reward shareholders without going through the rigmarole of paying dividends then getting taxed at source and G** knows where else for that matter. On the subject of dividends buying shares at these levels means you get @1.5% return on your investment. Only pointing out the obvious.

The Rat crossed the line when they advertised their services for Hire to a third party with the intention of discrediting them for financial gain. Whoever paid the rat is in deep trouble should a case be brought.